Aurobindo Shares Slump On US FDA Warning For Subsidiary

Shares in Aurobindo Pharma slumped following a warning letter to its subsidiary. "Further to our letter dated June 4, 2020, we would like to inform that the AuroLife Pharma LLC, a wholly owned stepdown subsidiary of the Company, has received a

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3oh5ZRt